TGM2 and cancer: Inhibition of TG2 by siRNA, antisense RNA or small-molecule inhibitors reversed the sensitivity of cancer cells to chemotherapeutic drugs and attenuated their invasion, both in vitro and in animal models [6,12-14,16][17].